The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...

Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

Cancer can often be difficult to detect in the early stages, particularly if it is a more 'subtle' form of the disease. So ...

A sunny day at Pumpkin Ridge Golf Club set the stage for the 12th annual Dunn's Duffers Charity Golf Tournament, organized by ...

Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

Not everyone gets a second chance at love—but Irish actor Pierce Brosnan, 72, counts his lucky stars that he found magic ...

Some forms of cancer can be difficult to detect in their early stages, especially if they have 'subtle' symptoms – so one ...

The published data showed that the combination of avutometinib plus defactinib demonstrated a confirmed overall response rate of 31% in all patients with recurrent low-grade serous ovarian cancer ...

Bayer receives UK MHRA approval for Lynkuet to treat moderate to severe vasomotor symptoms associated with menopause: Berlin Saturday, July 12, 2025, 10:00 Hrs [IST] Bayer announc ...